Dr. Joe Chuan Shih is the co-founder and chair of SAB of Anbogen Therapeutics. He is the venture partner at Lilly Asia Ventures. He is the co-inventor and led the development of Alimta®, the blockbuster drug at Eli Lilly and bozitinib at CrownBio.